Telegraph.co.uk

Six Nations 2012: cut all the gimmicks and gizmos, let the rugby entertain us Telegraph.co.uk By Mick Cleary One of the tracks that blared out every time someone went down injured at Murrayfield on Saturday was called, appropriately enough, Insomnia. Fat chance of ever getting to sleep with that racket ringing in the ears. and more »

View full post on insomnia – Google News

Merck tries new approach to treat insomnia MedCity News Peter S. Kim, president of Merck Research Laboratories said: “Suvorexant selectively targets an important pathway involved in helping to promote sleep and, if approved, will be a new, first-in-class treatment for patients with insomnia,” according to a …

View full post on insomnia – Google News

Merck Investors Can Sleep Easier (Not Easy) DailyFinance By Brian Orelli, The Motley Fool Posted 3:34PM 02/06/12 Investing Merck (NYS: MRK) said today that its insomnia drug suvorexant had passed two phase 3 trials, putting it on track for an FDA filing this year. But that doesn't mean investors can sleep …

View full post on insomnia – Google News

Merck Achieves Positive Results In Phase 3 Trials Of Insomnia Drug Wall Street Journal (MRK) said it achieved positive results in Phase 3 trials of its experimental insomnia treatment, a key drug in the pharmaceutical giant's pipeline. The company is working to bring successful new drugs to market to help offset the loss later this year …

View full post on insomnia – Google News

Merck Will Seek FDA Approval for Insomnia Drug (MRK) 24/7 Wall St. Drug giant Merck & Co. (NYSE: MRK) plans to file this year with the US FDA for approval of the company's newest sleep aid drug, suvorexant. The drug has completed late-stage trials with positive results. It is one of five drugs that Merck hopes will …

View full post on insomnia – Google News

What is Insomnia? The Culprit May Be Hyper-Arousal. OpEdNews By David Mayen (about the author) New evidenced based medicine is perhaps closing in on an answer to the age-old question of what is insomnia, what may the source of it's causes and new non-drug approaches in treating it effectively.

View full post on insomnia – Google News

Merck Provides Update on Development Program for Suvorexant, an … MarketWatch (press release) "Suvorexant selectively targets an important pathway involved in helping to promote sleep and, if approved, will be a new, first-in-class treatment for patients with insomnia," said Peter S. Kim, president, Merck Research Laboratories.

View full post on insomnia – Google News

Melatonin May Normalize Night Owl Sleep Schedules Clinical Psychiatry News Digital Network Bright light therapy in the evening," Dr. Zee said Patients with circadian sleep disorders don't have insomnia. Once asleep, they get a full night's rest. Even so, being out of synch with the world can cause problems. People with delayed phase … and more »

View full post on insomnia – Google News

Merck to File Insomnia Drug Application Wall Street Journal By PETER LOFTUS Merck & Co. said Monday that it plans to apply this year for US regulatory approval to market a potential new treatment for insomnia, based on positive clinical-trial results. The experimental drug, suvorexant, uses a new mechanism … Merck has positive Phase 3 insomnia trial resultsMarketWatch Merck Has Positive Results With New Insomnia DrugMedical News Today Merck to file application for new insomnia drugBizjournals.com NASDAQ -Reuters -DailyFinance all 50 news articles »

View full post on insomnia – Google News

Athens NEWS

Minerals may promote a good night's sleep Athens NEWS If these scenarios sound familiar, you could be experiencing insomnia. Millions of people suffer from insomnia and wonder if there is any treatment available. Statistics by the National Sleep Foundation and Better Sleep Council indicate that anywhere …

View full post on insomnia – Google News